Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $5.2 million.

  • Prokidney's Capital Expenditures rose 11618.14% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year increase of 52729.72%. This contributed to the annual value of $29.5 million for FY2024, which is 1370.88% down from last year.
  • Latest data reveals that Prokidney reported Capital Expenditures of $5.2 million as of Q3 2025, which was up 11618.14% from $3.1 million recorded in Q2 2025.
  • Prokidney's Capital Expenditures' 5-year high stood at $27.9 million during Q3 2023, with a 5-year trough of $306000.0 in Q4 2022.
  • For the 4-year period, Prokidney's Capital Expenditures averaged around $5.0 million, with its median value being $1.1 million (2025).
  • As far as peak fluctuations go, Prokidney's Capital Expenditures surged by 876952.38% in 2023, and later plummeted by 9139.55% in 2024.
  • Prokidney's Capital Expenditures (Quarter) stood at $306000.0 in 2022, then soared by 413.73% to $1.6 million in 2023, then soared by 1522.71% to $25.5 million in 2024, then crashed by 79.63% to $5.2 million in 2025.
  • Its Capital Expenditures was $5.2 million in Q3 2025, compared to $3.1 million in Q2 2025 and $1.1 million in Q1 2025.